Tag: neurofibromatosis type 1

EU green lights AZ, MSD’s rare disease therapy Koselugo

by Lucy Parsons | Jun 22, 2021 | News | 0

Drug approved to treat children with neurofibromatosis type 1 and plexiform neurofibromas

Read More

PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN

E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999